PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiac Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, China.\', \'Department of Microbiology, Linyi Center for Disease Control and Prevention, Linyi, China.\', \'Department of Immunology, School of Basic Medicine, Qingdao University, Qingdao, China.\', \'Department of Infectious Disease, The Affiliated Hospital of Qingdao University, Qingdao, China.\', \'Department of Medical Education, Qingdao Chest Hospital, Qingdao, China.\', \'Department of Infectious Disease, Qingdao Centre for Disease Control and Prevention, Qingdao Institute of Prevention Medicine, Qingdao, China.\', \'Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.690653
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34394084
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all